Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Three Way Takeover Battle – The End: Teva losing $300 million on Mylan stake

Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.

TEVA ,   EREZ VIGODMAN Robert-J-Coury-1 Mylan 320X=p

 

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has officially announced that it is withdrawing its bid to buy generic pharmaceuticals rival Mylan N.V. after agreeing to buy Allergan Generics for $40.5 billion. This leaves Teva with a 4.6% stake in Mylan, which it bought for about $1.6 billion, as part of its hostile takeover bid…

For the full story, click here

Published by Globes [online], Israel business news – www.globes-online.com

 

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Advertisement